Forget the SpaceX IPO. Thursday Is Space Earnings Day for Space Stocks BlackSky, Redwire, and Rocket Lab

BlackSky, Redwire, and Rocket Lab are all set to report Q1 earnings within the next 24 hours, with consensus looking for mixed fundamentals: BlackSky revenue down 8% to $27.3 million and a $0.40/share loss, Redwire sales up 70% to $104.6 million with a $0.17/share loss, and Rocket Lab sales up 54.5% to $189.4 million with losses narrowing to $0.08/share. The piece is primarily an earnings preview for three space stocks, alongside speculation about a future SpaceX IPO. Overall tone is neutral, with modest company-specific market impact.

Analysis

The market is likely to treat the three prints as a differentiated read-through on the space stack, not a single thematic trade. BlackSky looks like the weakest setup: lower-resolution demand is easier to substitute, and a revenue miss would reinforce the view that imagery is becoming a commoditized layer while the real value accrues to downstream analytics and defense integration. That makes BKSY vulnerable to multiple compression if management has to defend growth with pricing concessions or heavier customer concentration.

Redwire is the cleaner near-term beneficiary because it sits in the picks-and-shovels layer where program execution can hide slower end-demand. The Edge Autonomy acquisition creates an important second-order effect: investors may focus on revenue step-up, but the real question is gross margin mix and whether drone exposure becomes a cross-sell wedge into defense procurement budgets. If the company can show operating leverage even before full integration synergies, the stock can rerate sharply because the market is still discounting it as a low-quality hardware roll-up.

Rocket Lab remains the highest-quality optionality, but the next 24 hours are about proof of transition rather than headline growth. The key is whether space systems continues to out-earn launch enough to fund Neutron without capital-market dependence; if launch spend steps up faster than systems contribution, the stock could de-rate despite strong top-line numbers. The consensus seems to underappreciate that Neutron is the catalyst and the risk at the same time: success expands TAM into medium-lift, but any delay pushes the equity story back into a capital-intensive development asset.

Contrarian read: the market may be over-fixated on SpaceX as the only “must-own” space exposure, which can leave these public names mispriced around earnings execution. The better setup is not a sector-wide long, but a barbell between secular winners with real margin durability and weaker names where expectations are too low to protect downside. Over the next few months, the biggest move is likely not from these results alone, but from guidance on backlog conversion, launch cadence, and whether defense budgets are shifting toward integrated systems rather than point solutions.

Key Decisions for Investors

• Short BKSY into earnings or buy near-dated puts; thesis is that a modest revenue miss plus widening losses can trigger 15-25% downside as the market re-prices it as a lower-quality, more substitutable imaging asset.
• Long RDW on earnings strength only if margin commentary confirms Edge Autonomy integration is accretive; consider a post-print long with a 4-8 week horizon targeting a 20% rerating if revenue beats and operating leverage shows through.
• Use RKLB as a conditional long: buy post-earnings only if management reaffirms Neutron timing and capex discipline; otherwise avoid chasing a sales beat that may be offset by higher development burn.
• Pair trade: long RDW / short BKSY to express the view that the picks-and-shovels defense layer will outperform commoditized imagery over the next 1-2 quarters.
• For higher risk tolerance, structure RKLB call spreads 2-3 months out to capture a Neutron catalyst while capping premium bleed if launch timing slips.